2021 annual financial data
Regencell Bioscience 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -1,381,362 USD and net income was -1,346,745 USD.
Operating cash flow was -767,311 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -1,381,362 USD
- Net income
- -1,346,745 USD
- Operating cash flow
- -767,311 USD